company:eli-lilly Eli Lilly's big Summer 2025 update We take a look at some exciting upcoming presentations by Eli Lilly about it's old and new GLP1 receptor agonists.
drug:retatrutide An update on Retatrutide (May 2025) We take some time to check in on Retatrutide -- an update on how research and trials are progressing, and relevant news.
category:news A new GLP1: Retatrutide Is mimicking more hormones better? Let's find out -- the new GLP1 drug Retatrutide is a *triple* receptor agonist
